HemaSphere (Jun 2022)
P475: CONTROL LEUKEMIA BY INDUCING ANTI-CANCER IMMUNE REACTIVITY IN VIVO? POTENTIAL OF A DC-TRIGGERED MECHANISM
- G. Filippini Velazquez,
- D. Amberger,
- L. Klauer,
- E. Rackel,
- M. Atzler,
- S. Ugur,
- C. Plett,
- A. Rabe,
- C. Kugler,
- A. Rank,
- M. Inngjerdingen,
- T. Baudrexler,
- B. Eiz-Vesper,
- C. Schmid,
- H. Schmetzer
Affiliations
- G. Filippini Velazquez
- 1 Department of Hematology and Oncology, Section for Stem Cell Transplantation, Augsburg University Hospital, Augsburg
- D. Amberger
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- L. Klauer
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- E. Rackel
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- M. Atzler
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- S. Ugur
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- C. Plett
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- A. Rabe
- 3 Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway
- C. Kugler
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- A. Rank
- 1 Department of Hematology and Oncology, Section for Stem Cell Transplantation, Augsburg University Hospital, Augsburg
- M. Inngjerdingen
- 3 Institute of Clinical Medicine, Department of Immunology, University of Oslo, Oslo, Norway
- T. Baudrexler
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- B. Eiz-Vesper
- 4 Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
- C. Schmid
- 1 Department of Hematology and Oncology, Section for Stem Cell Transplantation, Augsburg University Hospital, Augsburg
- H. Schmetzer
- 2 Medical Department III, Department for Hematopoietic Cell Transplantation, Munich University Hospital, Munich, Germany
- DOI
- https://doi.org/10.1097/01.HS9.0000844788.89998.6c
- Journal volume & issue
-
Vol. 6
pp. 374 – 375
Abstract
No abstracts available.